← Back to All Filings

Merck CMO Sells $1.18M in Company Stock

Low SignificanceFebruary 9, 2026 at 4:07:50 PM EST

Merck & Co., Inc.

$MRK4CIK: 0000310158

Subscribe to track MRK

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Merck CMO Sells $1.18M in Company Stock

Company: Merck & Co., Inc. (MRK) Form: 4 | Filed: 2026-02-09 Significance: Low

Insider: Guindo Chirfi Title: Chief Marketing Officer | Relationship: Officer

Transaction: • Type: Sale • Shares: 10,000 • Price: $118.41 • Value: $1,184,101 • Owned After: 70,615

Key Insight: A $1.18M sale by the Chief Marketing Officer. While a large absolute number, the transaction is immaterial relative to Merck's $302.6B market cap, representing less than 0.001% of shares outstanding.

Comprehensive Analysis

SEC Filing Analysis: Merck & Co., Inc. (MRK)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The Chief Marketing Officer sold $1.18 million worth of company stock, a transaction that is immaterial given Merck's massive market capitalization.
  • Market Impact: The sale is too small to have any meaningful impact on the stock price or market sentiment.

Company Information

FieldValue
CompanyMerck & Co., Inc.
Ticker SymbolMRK
CIK0000310158
IndustryPharmaceutical Preparations

Insider Information

FieldValue
NameGuindo Chirfi
CIK0001722753
Title/PositionChief Marketing Officer
RelationshipOfficer

Transaction Details

FieldValue
Form Type4
Transaction Date2026-02-09
Transaction CodeS (Sale)
Security TypeCommon Stock
Shares Involved10,000
Price Per Share$118.4101
Total Value$1,184,101
Shares Owned After70,615.127
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$1,184,101
% of Market Cap0.00039%
Shares Transacted10,000
% of Shares Outstanding0.00040%
Post-Transaction Ownership70,615 shares (0.0028% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a mega-cap company like Merck with a market capitalization of over $302 billion, a transaction of $1.18 million is considered routine and financially insignificant.
  • Ownership Concentration: The sale represents approximately 12.4% of the insider's prior holdings. While a notable portion for the individual, the insider's total ownership remains very small relative to the total shares outstanding.
  • Transaction Significance: The transaction's value is less than 0.001% of the company's market cap and involves less than 0.001% of its outstanding shares. These metrics firmly place the transaction in the 'Low' significance category.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is too small to be considered a signal about the company's future prospects. Such sales by executives are common for personal financial management, diversification, or tax planning.

Volume & Sentiment

  • Expected Volume Impact: Negligible. The 10,000 shares transacted are a tiny fraction of Merck's daily trading volume.
  • Sentiment Indicator: Neutral. The market is unlikely to react to a sale of this size from a single executive at a company of this scale.

Additional Context

Transaction Notes

  • The sale was executed at a weighted average price of $118.4101, with prices ranging from $118.4000 to $118.4502.
Topics:#SECFiling#InsiderTrading#Form4#InsiderSell#MRK#Merck#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.